| Literature DB >> 6594712 |
R C Smith, R Baumgartner, G K Ravichandran, A Shvartsburd, J C Schoolar, P Allen, R Johnson.
Abstract
The relationship of plasma and red blood cell (RBC) levels of thioridazine to clinical response in schizophrenia was evaluated in a fixed-dose study. Steady-state plasma and RBC levels of thioridazine, mesoridazine, and sum of thioridazine and mesoridazine, determined by gas-liquid chromatography, were not significantly correlated with clinical response as measured by improvement on the Brief Psychiatric Rating Scale. RBC thioridazine levels were not substantially more strongly correlated with clinical response than plasma levels.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6594712 DOI： 10.1016/0165-1781(84)90045-3
Source DB: PubMed Journal: Psychiatry Res ISSN： 0165-1781 Impact factor: 3.222